The Department of Defense is putting the University of Nebraska in charge of an $ 11-Million effort to create drugs that would protect the military from the effects of radiation exposure.
University of Nebraska-Lincoln chemistry professor and project co-director, David Berkowitz, says such a drug would mean the military and civilians would have access to medication that would prevent radiation damage.
“That could obviously affect our war-fighters,” says Berkowitz.” It could also affect civilians if a Fukashima like nuclear accident would happen.”
Berkowitz says The University of Nebraska was able to secure the contract from the government thanks its proximity to STRATCOM and its reputation as a trusted research center.
He adds that in addition to fulfilling the Department of Defense’s contract, the project also has the secondary goal of increasing cooperation between UNL and UNMC.
Berkowitz hopes this project will be the first of many in what he calls the “Nebraska Drug Development Pipeline.”